✦ LIBER ✦

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors

✍ Scribed by Rheault, Tara R.; Stellwagen, John C.; Adjabeng, George M.; Hornberger, Keith R.; Petrov, Kimberly G.; Waterson, Alex G.; Dickerson, Scott H.; Mook, Robert A.; Laquerre, Sylvie G.; King, Alastair J.; Rossanese, Olivia W.; Arnone, Marc R.; Smitheman, Kimberly N.; Kane-Carson, Laurie S.; Han, Chao; Moorthy, Ganesh S.; Moss, Katherine G.; Uehling, David E.

Book ID: 118742950
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 815 KB
Volume: 4
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml4000063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Optimization of a Novel Se

Discovery and Optimization of a Novel Series of Potent Mutant B-Raf V600E Selective Kinase Inhibitors

✍ Vasbinder, Melissa M.; Aquila, Brian; Augustin, Martin; Chen, Huawei; Cheung, To 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 775 KB

383 POSTER A phase 1 study of XL281, a p

383 POSTER A phase 1 study of XL281, a potent and selective inhibitor of RAF kinases, administered orally to patients (pts) with advanced solid tumors

✍ G.K. Schwartz; S. Yazji; D.S. Mendelson; M.A. Dickson; S.H. Johnston; E.W. Wang; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

591 POSTER Antitumor activity of PLX4032

591 POSTER Antitumor activity of PLX4032, a selective V600EB-Raf inhibitor, as monotherapy and in combination with capecitabine ± bevacizumab in a colorectal cancer xenograft model

✍ K. Kolinsky; G. Bollag; R. Lee; K. Packman; D. Heimbrook; F. Su; B. Higgins 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

382 Phase II antitumor activity of BAY 4

382 Phase II antitumor activity of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in patients with sarcoma enrolled in a randomized discontinuation study

✍ S.C. Pacey; M.J. Ratain; P.O. O'Dwyer; H. Xiong; A. Patnaik; T. Eisen; D. Eaton; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 291 KB

A clinical phase I and biomarker study o

A clinical phase I and biomarker study of the Raf kinase inhibitor BAY 43-9006: preliminary evidence of activity in patients with advanced solid tumors

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 281 KB

254 In Vitro and in Vivo Antitumor Activ

254 In Vitro and in Vivo Antitumor Activity of the Investigational Aurora A Selective Kinase Inhibitor MLN8237 Alone and in Combination with Standard Agents Against CRC Models

✍ Pitts, T.M.; McPhillips, K.L.; Selby, H.M.; Spreafico, A.; Bagby, S.M.; Britt, B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB